Types of Antibiotic Salmonella spp Shigellaspp
Frequency (%) Frequency (%)
TE R 21(52.5) 14(82.4)
  I 16(40.0) 3(17.6)
  S 3(7.5%) 0(0.0)
AMP R 24(60.0) 8(47.1)
  I 15 (37.5) 5(29.4)
  S 1(2.5) 4(23.5)
SXT R 15(37.5) 13(76.5)
  I 2(5.0) 0(0.0)
  S 23(57.5) 4(23.5)
C R 4(10.0) 5(29.4)
  I 7(17.5) 1(5.9)
  S 29(72.5) 11(64.7)
GM R 2(5.0) 3(17.6)
  I 17(42.5) 4(23.5)
  S 21(52.5) 10(58.8)
NA R 2(5.0) 1(5.9)
  I 7(17.5) 1(5.9)
  S 31(77.5) 15(88.2)
CIP R 1(2.5) 1(5.9)
  I 2(5.0) 1(5.9)
  S 37(92.5) 15(88.2)
CRO R 0(0.0) 0(0.0)
  I 6(15.0) 0(0.0)
  S 34(85.0) 17(100.0)
AMP=Ampicillin, C=Chloramphenicaol, CIP=Ciprofloxacin, CRO=Ceftriaxone, SXT=Cotrimoxazole, TE=Tetracycline, NA=Nalidixic Acid, GM=Gentamicin, R=Resistant, I=Intermediate, S=Sensitive
Table 2: The in vitro antimicrobial susceptibility patterns of Salmonella and Shigella isolates identified in the Butajira Health center, Ethiopia from October 2011 to June 2012